Own 500 Pfizer and JNJ Shares: Here’s Your Dividend Income
Healthcare megacaps Pfizer and Johnson & Johnson continue to deliver quarterly dividends that can generate reliable i...
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,624 articlesHealthcare megacaps Pfizer and Johnson & Johnson continue to deliver quarterly dividends that can generate reliable i...
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
Cathie Wood's selling moves can offer valuable lessons for investors. This article breaks down why cathie wood goes s...
When a Fed chair speaks about prices being too high, markets hear implications for rates. This article unpacks what t...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
The Baupost founder made a bold, selective move: trim a large Alphabet stake and pivot to a fintech name that slumped...
A fresh look at a chilling historical echo: the 1987 omen: kevin warsh's. As markets brace for a new Fed chair, inves...
Inflation can quietly erode fixed income’s purchasing power. This practical, straightforward guide shows you how to t...
Thinking about retirement by the end of 2026? This guide outlines three essential moves to secure your financial foun...
A headline about Palantir and a high-stakes defense AI plan could reshape risk and opportunity. This guide breaks dow...
Defiance’s 2X inverse ETF tied to SMCI confronts a classic risk now that SMCI has reported after hours. The fund’s da...
NVDY is pursuing income by selling Nvidia’s strongest move days, financing a roughly 60% distribution. The strategy b...